Assignity Revenue and Competitors
Employee Data
- Assignity has 42 Employees.
- Assignity grew their employee count by 40% last year.
Assignity's People
Name | Title | Email/Phone |
---|
Assignity Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 42 | 40% | N/A | N/A |
#2 | N/A | 180 | 41% | N/A | N/A |
#3 | N/A | 24 | 9% | N/A | N/A |
What Is Assignity?
Assignity is an independent consultancy specialising in Health Economics and Outcomes Research (HEOR) and Pricing, Reimbursement and Market Access (PRMA). Our team of scientific and strategic experts support pharmaceutical companies directly or through other consulting organisations, with the goal to bring new treatments to patients. \nAssignity was set up by a group of six experts in HEOR and PRMA. We have been working together in the field of life sciences for more than 10 years and have built an authentic, professional, and trustworthy team.\n\nOur services include:\n- Evidence Synthesis\n- Data Analytics\n- Economic Modelling\n- Health Technology Assessment\n- Value Communication\n- Pricing and Reimbursement\n\nEfficient partner for Pharma\n\nThe challenges faced by each new technology are different and require dedicated and flexible support. We offer in-depth involvement of senior team members at each project step, to fulfil the expectations of pharmaceutical companies for quality, flexibility and creativity.\n\nFlexible support for Consulting Companies\n\nThe limitations in human resources and variations in workload do not always allow for sufficient commitment from in-house staff to fulfil the needs of every project. Assignity can help consulting companies with the execution of complex projects or specific project parts.
keywords:N/AN/A
Total Funding
42
Number of Employees
N/A
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 43 | 30% | N/A |
#2 | $4.4M | 43 | 43% | N/A |
#3 | $2.7M | 45 | 50% | N/A |
#4 | $2.7M | 47 | -4% | N/A |
#5 | $7.8M | 48 | -30% | N/A |